Dr Stephen Blatcher
Head of Early-Stage MedTech

About

Stephen Blatcher, PhD, joined Team Consulting’s commercial team in 2019 to help expand the company’s work in the MedTech space. With a particular focus on high-risk devices, his strategic business skills and background in engineering and biotechnology give him an aptitude for both managing technical projects and developing business opportunities.

Contributions

EXPERT VIEW

PREPARING FOR MASS VACCINATION

Andy Fry and Stephen Blatcher discuss the need for a mass vaccination device in response to the 2020 covid-19 pandemic. In particular, the authors discuss the benefits and challenges of turning to needle-free injection technology as a solution.